Max Healthcare discussion room

A mid-cap hospitals platform where occupancy and bed-expansion returns matter more than the healthcare-premium narrative. The deep-research frame starts with multi-specialty hospitals, high-acuity care, and selective expansion in dense urban healthcare markets The management layer is doctor retention, specialty mix, and scaling beds without diluting mature-asset economics, while the capital-allocation question is capital allocation into brownfield and greenfield capacity versus cash returns. On future value, I think the room has to decide whether Max can keep compounding as a high-quality hospital operator while it scales the next capacity cycle. The financial scoreboard is occupancy, ARPOB, EBITDA per bed, and return on new hospital investments. Before calling this durable or fragile, I want hard evidence on returns on new beds and mature-hospital occupancy. What would you put on the must-verify list first?